Labcorp will spin-off its wholly owned clinical development business, with the expectation that it will become an independent, publicly traded company. Labcorp will remain in Burlington and focus on its laboratory services.
Labcorp will spin-off its wholly owned clinical development business, with the expectation that it will become an independent, publicly traded company. Labcorp will remain in Burlington and focus on its laboratory services.
